SCHEMBL24624979

SCHEMBL24624979

CC(C)(C)[Si](C)(C)OCc1cc(CO[Si](C)(C)C(C)(C)C)[nH]n1

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ HCAR2 Q8TDS4 1/20 0.34
▸ DUT P33316 2/20 0.31
▸ HPGD P15428 1/20 0.30
▸ TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25934687 0.90 HCAR2 (0.31) HCAR2
SCHEMBL25934682 0.90 HCAR2 (0.34) HCAR2
SCHEMBL26927340 0.86 GPR84 (0.33) HCAR2DUT
SCHEMBL23530049 0.83 HCAR2 (0.33) HCAR2
SCHEMBL31284378 0.81 DUT (0.30) DUT
SCHEMBL26927028 0.79 LMNA (0.32) HCAR2
SCHEMBL26140216 0.78 KDM5A (0.30) —
SCHEMBL26927565 0.78 BTK (0.30) —
SCHEMBL25934680 0.76 HCAR2 (0.50) HCAR2
SCHEMBL24914924 0.74 KMT2A (0.46) HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025082283-A1 LIGAND COMPOUND OF CYCLOPEPTIDE STRUCTURE, NUCLIDE MARKER THEREOF, PHARMACEUTICAL COMPOSITION, AND USE 四川科伦博泰生物医药股份有限公司 2025-04-24 — — WO disclosed
US-20230270868-A1 PYRROLOBENZODIAZEPINE DIMER PRODRUG AND LIGAND-LINKER CONJUGATE COMPOUND OF THE SAME LIGACHEM BIOSCIENCES INC. (KR) 2023-08-31 — — US disclosed
US-11654197-B2 Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same LEGOCHEM BIOSCIENCES, INC. (KR) 2023-05-23 — — US disclosed
US-20220218830-A1 PYRROLOBENZODIAZEPINE DIMER PRODRUG AND LIGAND-LINKER CONJUGATE COMPOUND OF THE SAME LIGACHEM BIOSCIENCES INC. (KR) 2022-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220218830-A1 PYRROLOBENZODIAZEPINE DIMER PRODRUG AND LIGAND-LINKER CONJUGATE COMPOUND OF THE SAME GABRP, GABRD, GABBR2 HCAR2 21/4885DUT 735/4885HPGD 415/4885
US-11654197-B2 Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same GABRP, GABRD, GABBR2 HCAR2 21/4885DUT 735/4885HPGD 415/4885
US-20230270868-A1 PYRROLOBENZODIAZEPINE DIMER PRODRUG AND LIGAND-LINKER CONJUGATE COMPOUND OF THE SAME BCR, PIN1, PAICS HCAR2 144/4885DUT 839/4885HPGD 779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback